Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives

Psychiatric Services

Volumn 61, Issue 4, 2010, Pages 380-385

  Wilder, Christine M ^a   Elbogen, Eric B ^b   Moser, Lorna L ^a   Swanson, Jeffrey W ^a   Swartz, Marvin S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; BENZATROPINE; CARBAMAZEPINE; CHLORPROMAZINE; CLONAZEPAM; ESCITALOPRAM; FLUOXETINE; FLUPHENAZINE; GABAPENTIN; HALOPERIDOL; LITHIUM; LORAZEPAM; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; THIORIDAZINE; TRAZODONE; TRIFLUOPERAZINE; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

ADULT; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PRESCRIPTION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

EID: 77950820280     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2010.61.4.380     Document Type: Article

References (46)

1. Bebbington PE: The content and context of compliance. International Clinical Psychopharmacology 9(suppl 5):41-50, 1995
2. Perkins DO: Adherence to antipsychotic medications. Journal of Clinical Psychiatry 60(suppl 21):25-30, 1999
3. Rittmannsberger H, Pachinger T, Keppelmuller P, et al: Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatric Services 55:174-179, 2004
4. Scott J, Pope M: Nonadherence with mood stabilizers: prevalence and predictors. Journal of Clinical Psychiatry 63:384-390, 2002
5. Weiden PJ, Kozma C, Grogg A, et al: Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55:886-891, 2004
6. Rogers A, Day JC, Williams B, et al: The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. Social Science and Medicine 47:1313-1323, 1998
7. Bissell P, May CR, Noyce PR: From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Social Science and Medicine 58:851-862, 2004
8. Mitchell AJ: Adherence behaviour with psychotropic medication is a form of selfmedication. Medical Hypotheses 68:12-21, 2007
9. Srebnik D, LaFond J: Advance directives for mental health services: current perspectives and future directions. Psychiatric Services 50:919-925, 1999
10. Swanson JW, Tepper MC, Backlar P, et al: Psychiatric advance directives: an alternative to coercive treatment? Psychiatry 63:160-172, 2000
11. Swartz MS, Stroup TS, McEvoy JP, et al: What CATIE found: results from the schizophrenia trial. Psychiatric Services 59:500-506, 2008
12. Falkai P: Limitations of current therapies: why do patients switch therapies? European Neuropsychopharmacology 18(suppl 3):S135-S139, 2008
13. Fleck DE, Keck PE Jr, Corey KB, et al: Factors associated with medication adherence in African American and white patients with bipolar disorder. Journal of Clinical Psychiatry 66:646-652, 2005
14. Johnson FR, Ozdemir S, Manjunath R, et al: Factors that affect adherence to bipolar disorder treatments: a stated-preference approach. Medical Care 45:545-552, 2007
15. Robinson DG, Woerner MG, Alvir JMJ, et al: Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research 57:209-219, 2002
16. Holzinger A, Loffler W, Muller P, et al: Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia. Journal of Nervous and Mental Disease 190:597-603, 2002
17. Verdoux H, Lengronne J, Liraud F, et al: Medication adherence in psychosis: predictors and impact on outcome: a 2-year follow-up of first-admitted subjects. Acta Psychiatrica Scandinavica 102:203-210, 2000
18. Coldham EL, Addington J, Addington D: Medication adherence of individuals with a first episode of psychosis. Acta Psychiatrica Scandinavica 106:286-290, 2002
19. Day JC, Bentall RP, Roberts C, et al: Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Archives of General Psychiatry 62:717-724, 2005
20. Kozuki Y, Froelicher ES: Lack of awareness and nonadherence in schizophrenia. Western Journal of Nursing Research 25:57-74, 2003
21. Tunis SL, Faries DE, Stensland MD, et al: An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia. Current Medical Research and Opinion 23:97-104, 2007
22. Draine J, Solomon P: Explaining attitudes toward medication compliance among a seriously mentally ill population. Journal of Nervous and Mental Disease 182:50-54, 1994
23. Seo MA, Min SK: Development of a structural model explaining medication compliance of persons with schizophrenia. Yonsei Medical Journal 46:331-340, 2005
24. Howgego IM, Yellowlees P, Owen C, et al: The therapeutic alliance: the key to effective patient outcome? A descriptive review of the evidence in community mental health case management. Australian and New Zealand Journal of Psychiatry 37:169-183, 2003
25. Patall EA, Cooper H, Robinson JC: The effects of choice on intrinsic motivation and related outcomes: a meta-analysis of research findings. Psychological Bulletin 134:270-300, 2008
26. Williams G, Freedman Z, Deci E: Supporting autonomy to motivate patients with diabetes for glucose control. Diabetes Care 21:1644-1651, 1998 (Pubitemid 28449801)
27. Williams G, Rodin G, Ryan R, et al: Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychology 17:269-276, 1998 (Pubitemid 28277121)
28. Bellg A: Maintenance of health behavior change in preventive cardiology: internalization and self-regulation of new behaviors. Behavior Modification 27:103-131, 2003
29. Scheyett A, Kim M, Swanson J, et al: Psychiatric advance directives: a tool for consumer empowerment and recovery. Psychiatric Rehabilitation Journal 31:70-75, 2007 (Pubitemid 47080860)
30. Elbogen E, Swanson JW, Swartz MS, et al: Effectively implementing psychiatric advance directives to promote self-determination of treatment among people with mental illness. Psychology, Public Policy, and Law 13:273-288, 2007
31. Henderson C, Swanson JW, Szmukler G, et al: A typology of advance statements in mental health care. Psychiatric Services 59:63-71, 2008
32. Swanson JW, Swartz MS, Elbogen EB, et al: Facilitated psychiatric advance directives: a randomized trial of an intervention to foster advance treatment planning among persons with severe mental illness. American Journal of Psychiatry 163:1943-1951, 2006
33. Kim M, Van Dorn RA, Scheyett AM, et al: Understanding the personal and clinical utility of psychiatric advance directives: a qualitative perspective. Psychiatry 70:19-29, 2007
34. Srebnik D, Rutherford LT, Peto T, et al: The content and clinical utility of psychiatric advance directives. Psychiatric Services 56:592-598, 2005
35. Hammes BJ, Rooney BL: Death and endof-life planning in one midwestern community. Archives of Internal Medicine 158:383-390, 1998
36. Advance Health Care Directives. Pub no 5088.01. Sacramento, Calif, Protection and Advocacy, 2000
37. Colvin ER, Hammes BJ: "If I only knew": a patient education program on advance directives. ANNA Journal 18:557-560, 1991
38. Elbogen EB, Swartz MS, Van Dorn RA, et al: Clinical decision making and views about psychiatric advance directives. Psychiatric Services 57:350-355, 2006
39. Byerly M, Thompson A, Carmody T, et al: Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatric Services 58:844-847, 2007
40. Velligan DI, Wang M, Diamond P, et al: Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatric Services 58:1187-1192, 2007
41. Moerner MG, Mannuzza S, Kane JM: Anchoring the BPRS: an aid to improved reliability. Psychopharmacology Bulletin 24:112-117, 1988
42. Mayfield D, McLeod G, Hall P: The CAGE questionnaire: validation of a new alcoholism instrument. American Journal of Psychiatry 131:1121-1123, 1974
43. Brown RL, Rounds LA: Conjoint screening questionnaires for alcohol and drug abuse. Wisconsin Medical Journal 94:135-140, 1995
44. Leucht S, Kane JM, Kissling W, et al: Clinical implications of Brief Psychiatric Rating Scale scores. British Journal of Psychiatry 187:366-371, 2005
45. Srebnik D, Rutherford L, Peto T: The content and clinical utility of psychiatric advance directives. Psychiatric Services 56:592-598, 2005
46. Remington G, Kwon J, Collins A, et al: The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophrenia Research 90:229-237, 2007